As I walked into a one-on-one interview with Baekhyun, one of the top-tier K-pop talents in the industry, I was greeted with ...
Roche gets the first FDA approval for a diagnostic test for HER2-ultralow breast cancer, now on the label of AstraZeneca and Daiichi Sankyo's Enhertu.